STADA Arzneimittel AG, DE0007251803

STADA Arzneimittel AG, DE0007251803

15.09.2017 - 11:33:58

STADA Arzneimittel AG: Information on financing of the Takeover Offer

Bad Vilbel, September 15, 2017 - In the context of financing of the takeover offer of Nidda Healthcare Holding AG, the acquiring company of Bain Capital and Cinven, STADA Arzneimittel AG today published on its website under www.stada.com/additional-financial-information a report referred to as "Information Release".

Contact: STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2-18 / 61118 Bad Vilbel - Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0) 6101 603-215 / E-mail: leslie.iltgen@stada.de

Or visit us in the Internet at www.stada.com.

15.09.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel

Germany Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de Internet: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange   End of News DGAP News Service

610047  15.09.2017 

@ dgap.de